Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Not applicableStudy completedNCT02491177
What this trial is testing

Mother and Infant Visit Adherence and Treatment Engagement Study

Who this might be right for
Human Immunodeficiency Virus
University of Colorado, Denver 1,338
Large-scale testing (Phase 3)UnknownNCT04022967
What this trial is testing

ANRS 12372 MODERATO Study

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 480
Testing effectiveness (Phase 2)Study completedNCT00080106
What this trial is testing

Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Not applicableUnknownNCT06019273
What this trial is testing

Impacts of Different ART Regimens on Lipid Metabolism in People Living With HIV

Who this might be right for
HIV InfectionCombined Antiretroviral Therapy
First Affiliated Hospital of Zhejiang University 180
Not applicableStudy completedNCT00034086
What this trial is testing

Study of Anti-HIV Therapy Intensification

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 22
Not applicableStudy completedNCT00016783
What this trial is testing

Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 39
Not applicableStudy completedNCT01154556
What this trial is testing

RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice

Who this might be right for
HIV Positive
Holdsworth House Medical Practice 2,044
Post-approval studies (Phase 4)Study completedNCT00108862
What this trial is testing

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Who this might be right for
HIV InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 809
Testing effectiveness (Phase 2)Ended earlyNCT01026727
What this trial is testing

Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

Who this might be right for
HIV Infections
Myrexis Inc. 2
Large-scale testing (Phase 3)WithdrawnNCT00011128
What this trial is testing

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT03848728
What this trial is testing

Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa

Who this might be right for
HIV
University of California, San Francisco 1,988
Large-scale testing (Phase 3)Study completedNCT02178592
What this trial is testing

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 113
Early research (Phase 1)Study completedNCT05245292
What this trial is testing

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 28
Post-approval studies (Phase 4)Looking for participantsNCT07616739
What this trial is testing

Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women

Who this might be right for
HIV-1-infection
Fundación Huésped 210
Post-approval studies (Phase 4)Temporarily pausedNCT00143728
What this trial is testing

3TC or No 3TC for HIV With 3TC Resistance

Who this might be right for
HIV Infections
University of British Columbia 152
Not applicableLooking for participantsNCT06541028
What this trial is testing

Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)

Who this might be right for
HivDrug Use
Yale University 135
Not applicableStudy completedNCT00100581
What this trial is testing

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableStudy completedNCT02890459
What this trial is testing

Innovative Behavioral Economics Incentives Strategies for Health

Who this might be right for
HIV/AIDS
University of California, San Francisco 3,580
Large-scale testing (Phase 3)Study completedNCT00381303
What this trial is testing

GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.

Who this might be right for
HIVInfectious
Tibotec, Inc 429
Post-approval studies (Phase 4)Study completedNCT00753324
What this trial is testing

Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 284
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation